Literature DB >> 30593716

Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss.

Jinhwan Park1, Sehyun Baek1.   

Abstract

PURPOSE: To compare the structure and function of the Meibomian gland and eyelid blinking patterns between thyroid eye disease (TED) patients with dry eye and nonthyroidal dry eye (DE) patients.
METHODS: This was a prospective, cross-sectional and observational study. Clinical measurements were performed as follows: (1) external examination, (2) Lipiview® Interferometer (lipid layer thickness, incomplete blinking rate and meibography) and (3) slit-lamp biomicroscopy (corneal staining, tear break-up time (TBUT), meibum expression).
RESULTS: The TED and DE groups included 98 and 62 patients, respectively. The meiboscores of the upper eyelid in TED and DE groups were significantly different (1.21 ± 0.76 and 0.94 ± 0.71, respectively, p = 0.046). The rate of incomplete blinking was 53.3 ± 34.5 and 34.6 ± 36.3%, respectively, and was significantly higher in the TED group (p = 0.006). In the TED group, CAS was the only variable affecting the meiboscore of the upper and lower eyelids (p = 0.031, 0.039, respectively). Significantly, active TED patients had more decreased basal tear secretion than inactive TED patients (7.4 ± 2.1 mm versus 8.5 ± 1.5 mm, p = 0.024). Moreover, active TED patients had decreased meibum expression in both upper and lower eyelids compared with inactive TED patients (2.20 ± 0.88 versus 1.08 ± 0.84, p = 0.002 in upper eyelid, 2.10 ± 0.88 versus 1.18 ± 0.88, p = 0.007 in lower eyelid, respectively).
CONCLUSION: In TED patients, incomplete blinking and loss of Meibomian gland structure in the upper eyelid were more prominent than in DE patients. CAS was a factor affecting the structural loss of Meibomian glands in TED individuals.
© 2018 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blinking; dry eye; meibomian gland dysfunction; thyroid eye disease

Mesh:

Substances:

Year:  2018        PMID: 30593716     DOI: 10.1111/aos.14000

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

Review 1.  Ocular surface disease in thyroid eye disease: A narrative review.

Authors:  Harkaran S Rana; Sruti S Akella; Carson E Clabeaux; Zachary P Skurski; Vinay K Aakalu
Journal:  Ocul Surf       Date:  2022-02-12       Impact factor: 6.268

2.  Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease.

Authors:  Lei Tian; Ya Wen; Siyuan Li; Peng Zhang; Yinghui Wang; Jingyi Wang; Kai Cao; Lihua Du; Ningli Wang; Ying Jie
Journal:  Front Nutr       Date:  2022-01-13

3.  Mean Tear-Film Lipid Layer Thickness and Video Display Terminal Time as Risk Factors for Abnormal Blinking in Children.

Authors:  Hui Zhao; Shi-Nan Wu; Zhe Cheng; Dong Xiao; Hui-Ye Shu; Qian-Min Ge; Tian Tian; Yi Shao
Journal:  Front Med (Lausanne)       Date:  2021-12-06

4.  Changes in Dry Eye Status after Steroid Pulse and Orbital Radiation Therapies in Active Thyroid Eye Disease.

Authors:  Yasuhiro Takahashi; Aric Vaidya; Hirohiko Kakizaki
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

5.  In vivo confocal microscopy assessment of meibomian glands microstructure in patients with Graves' orbitopathy.

Authors:  Shengnan Cheng; Yueqi Yu; Jin Chen; Lin Ye; Xinghua Wang; Fagang Jiang
Journal:  BMC Ophthalmol       Date:  2021-06-19       Impact factor: 2.209

6.  Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study.

Authors:  Ibrahim Y Allam; Sihem Lazreg; Mohamed Shafik Shaheen; Mohamed Fahmy Doheim; Mai A Mohammed
Journal:  Clin Ophthalmol       Date:  2021-06-15

7.  Tear film break-up patterns in thyroid eye disease.

Authors:  Yasuhiro Takahashi; Patricia Ann L Lee; Aric Vaidya; Shinjiro Kono; Hirohiko Kakizaki
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.